Viracta Therapeutics (VIRX) Stock Chart & Stock Price History → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free VIRX Stock Alerts $0.81 +0.00 (+0.37%) (As of 12:57 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Viracta Therapeutics Stock Price Performance5 Day Performance-3.93%1 Month Performance-5.80%3 Month Performance+13.66%6 Month Performance+46.73%Year-To-Date Performance+41.58%1 Year Performance-62.02% Receive VIRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry VIRX Stock Chart for Monday, May, 20, 2024 VIRX Chart by TradingView Viracta Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$0.81$0.81-0.38%$0.87$0.8170,761 shs$31.69 million05/16/2024$0.84$0.81-3.56%$0.89$0.8058,371 shs$31.81 million05/15/2024$0.80$0.84+4.48%$0.87$0.79141,574 shs$32.99 million05/14/2024$0.77$0.80+4.28%$0.84$0.7630,813 shs$31.57 million05/13/2024$0.76$0.77+1.45%$0.81$0.7639,561 shs$30.28 million05/10/2024$0.83$0.76-7.88%$0.84$0.7689,165 shs$29.85 million Get the Latest News and Ratings for VIRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$0.82$0.83+0.49%$0.84$0.8156,518 shs$32.40 million05/08/2024$0.82$0.82+0.12%$0.84$0.8126,818 shs$32.24 million05/07/2024$0.80$0.82+2.49%$0.84$0.8122,919 shs$32.20 million05/06/2024$0.81$0.80-1.25%$0.84$0.7938,197 shs$31.42 million05/03/2024$0.84$0.81-3.55%$0.84$0.8033,087 shs$31.82 million05/02/2024$0.82$0.84+2.43%$0.85$0.8160,535 shs$32.99 million05/01/2024$0.82$0.82+0.06%$0.88$0.8019,309 shs$32.21 million04/30/2024$0.82$0.82-0.05%$0.90$0.8140,743 shs$32.19 million04/29/2024$0.83$0.82-1.00%$0.86$0.8184,450 shs$32.20 million04/26/2024$0.85$0.83-1.88%$0.85$0.8236,424 shs$32.64 million04/25/2024$0.84$0.85+1.28%$0.86$0.8237,827 shs$33.26 million04/24/2024$0.85$0.84-1.36%$0.90$0.8355,053 shs$32.84 million04/23/2024$0.88$0.85-3.66%$0.91$0.7683,968 shs$33.29 million04/22/2024$0.86$0.88+2.72%$0.90$0.8413,375 shs$34.56 million04/19/2024$0.91$0.86-5.75%$0.91$0.8252,613 shs$33.64 million04/18/2024$0.94$0.91-3.55%$0.99$0.8579,390 shs$35.70 million04/17/2024$0.71$0.94+31.86%$0.95$0.74195,773 shs$37.01 million04/16/2024$0.78$0.71-8.36%$0.82$0.67255,596 shs$28.07 million04/15/2024$1.15$0.78-32.17%$1.04$0.76605,380 shs$30.63 million04/12/2024$1.17$1.15-1.71%$1.31$1.08329,545 shs$45.16 million04/11/2024$1.14$1.17+2.63%$1.31$1.10347,238 shs$45.95 million04/10/2024$1.06$1.14+7.55%$1.14$1.0372,221 shs$44.77 million04/09/2024$1.07$1.06-0.93%$1.11$1.0276,539 shs$41.63 million04/08/2024$1.02$1.07+4.90%$1.10$1.03143,410 shs$42.02 million04/05/2024$1.04$1.02-1.92%$1.08$0.9965,586 shs$40.06 million04/04/2024$1.09$1.04-4.59%$1.11$1.0176,044 shs$40.84 million04/03/2024$1.09$1.09$1.09$1.0571,985 shs$42.80 million04/02/2024$1.11$1.09-1.80%$1.12$1.05111,205 shs$42.80 million04/01/2024$1.02$1.11+8.82%$1.14$1.04255,023 shs$43.59 million03/29/2024$1.02$1.02$1.08$0.9760,037 shs$40.06 million03/28/2024$1.08$1.02-5.56%$1.08$0.9859,239 shs$40.06 million03/27/2024$1.08$1.08$1.10$1.0532,885 shs$42.41 million03/26/2024$1.06$1.08+1.89%$1.11$1.0536,430 shs$42.41 million03/25/2024$0.97$1.06+9.28%$1.15$0.94101,485 shs$41.63 millionThis Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry03/22/2024$1.07$0.97-9.35%$1.05$0.95126,350 shs$38.09 million03/21/2024$1.13$1.07-5.31%$1.17$1.0689,078 shs$42.02 million03/20/2024$1.01$1.13+11.88%$1.13$0.9881,672 shs$44.38 million03/19/2024$0.99$1.01+2.02%$1.04$0.9876,968 shs$39.66 million03/18/2024$1.00$0.99-0.60%$1.01$0.9583,443 shs$38.88 million03/15/2024$0.97$1.00+2.68%$1.04$0.9439,807 shs$39.11 million03/14/2024$0.95$0.97+2.11%$0.98$0.9447,553 shs$38.09 million03/13/2024$0.99$0.95-3.55%$1.05$0.9576,703 shs$37.31 million03/12/2024$0.89$0.99+10.66%$1.05$0.93241,419 shs$38.68 million03/11/2024$0.85$0.89+4.68%$0.96$0.8697,141 shs$34.95 million03/08/2024$0.81$0.85+4.96%$0.94$0.80236,360 shs$33.36 million03/07/2024$0.92$0.81-11.92%$0.95$0.80176,824 shs$31.78 million03/06/2024$0.94$0.92-2.64%$0.94$0.9060,343 shs$36.08 million03/05/2024$0.94$0.94+0.49%$0.98$0.91103,808 shs$37.06 million03/04/2024$0.91$0.94+3.29%$1.00$0.91161,918 shs$36.88 million03/01/2024$0.82$0.91+11.67%$0.94$0.80152,548 shs$35.15 million02/29/2024$0.89$0.82-8.43%$0.92$0.76190,182 shs$31.48 million02/28/2024$0.76$0.89+17.11%$0.95$0.77132,023 shs$34.37 million02/27/2024$0.71$0.76+7.34%$0.79$0.7074,370 shs$29.35 million02/26/2024$0.70$0.71+1.14%$0.72$0.6877,710 shs$27.34 million02/23/2024$0.71$0.70-1.75%$0.73$0.6930,428 shs$27.03 million02/22/2024$0.70$0.71+2.52%$0.74$0.6924,055 shs$27.52 million02/21/2024$0.71$0.70-2.11%$0.74$0.6891,943 shs$26.84 million02/20/2024$0.68$0.71+4.41%$0.74$0.68171,892 shs$27.42 million02/19/2024$0.68$0.68$0.75$0.62274,800 shs$26.27 million Related Companies: IPA Stock Price Chart DARE Stock Price Chart APLM Stock Price Chart APRE Stock Price Chart ACXP Stock Price Chart THTX Stock Price Chart NRXP Stock Price Chart BCTX Stock Price Chart FBIO Stock Price Chart SPRB Stock Price Chart Receive VIRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VIRX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDoes this make you sick?Allegiance GoldThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viracta Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.